KellyCraneSandbergMDMSc

Pediatric Gastroenterology • Dayton, OH

Pediatric Inflammatory Bowel Disease Gastroenterology

Chief Medical Quality Officer at Dayton Children’s Hospital

Join to view full profile

Dr. Sandberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sandberg's full profile

Already have an account?

Office
1 Childrens Plz
Dayton, OH 45404
Phone+1 937-641-4000

Fax+1 937-641-4500

Summary

Dr. Kelly Sandberg is a pediatric gastroenterologist in Dayton, OH and is affiliated with Dayton Children's Hospital. He received his medical degree from University of Arizona College of Medicine-Tucson and has been in practice 13 years. He specializes in pediatric inflammatory bowel disease gastroenterology and is experienced in pediatric gastroenterology and pediatric inflammatory bowel disease. He has more than 20 publications and over 80 citings.

Education & Training

University of MichiganMSc, Pediatric Health Services Research, 2012 - 2014
University of MichiganFellowship, Pediatric Gastroenterology, 2011 - 2014
Nationwide Children's Hospital/Ohio State UniversityInternship, Pediatrics, 2008 - 2011
University of Arizona College of MedicineClass of 2008

Certifications & Licensure

OH State Medical License 2008 - 2026
MI State Medical License 2011 - 2015
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Gastroenterology
Cincinnati Children's HospitalIntermediate Improvement Science Series (I2S2)
Intermountain HealthcareAdvanced Training Program-4 months

Awards, Honors, & Recognition

Foundation Board Grant Dayton Children's Board, 2022
Innovation Grant ImproveCareNow, David R. Clare and Margaret C. Clare Foundation, 2018-2020

Clinical Trials

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Start of enrollment: 2016 Oct 01
Completed
Phase 3

Publications & Presentations

PubMed

A Quality Improvement Initiative to Decrease Behavioral Health Unit Readmission Rates.
Katherine Winner, Kelly Sandberg, Brandon Saia, Megan Calabro, Kelly Blankenship
Pediatrics. 2025-01-21
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's Disease.
Jeremy Adler, Joseph A Galanko, Rana Ammoury, Keith J Benkov, Athos Bousvaros
The American Journal of Gastroenterology. 2024-10-18
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.
Jonathan Moses, Jeremy Adler, Shehzad A Saeed, Ann M Firestine, Joseph A Galanko
Inflammatory Bowel Diseases. 2024-10-17